Related Experiment Video
Updated: Jun 16, 2026

07:30
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials
Baoji Hu1, Jiangbin Yan2, Wentao Ji2
1Department of Anesthesiology, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China.
Frontiers in Immunology
|June 15, 2026
Summary
V-domain Ig suppressor of T cell activation (VISTA) plays a dual role in sepsis, initially reducing inflammation and later promoting immune suppression. Targeting VISTA offers a promising therapeutic strategy for sepsis treatment.
Area of Science:
- Immunology
- Pathophysiology
- Critical Care Medicine
Background:
- Sepsis is a life-threatening organ dysfunction due to dysregulated host response to infection.
- Immune system dysregulation is central to sepsis pathophysiology.
- V-domain Ig suppressor of T cell activation (VISTA) is an immune checkpoint molecule with a key role in sepsis.
Purpose of the Study:
- To review VISTA's dynamic expression and immunoregulatory roles in sepsis.
- To synthesize evidence on VISTA's mechanisms in sepsis.
- To evaluate VISTA-targeted interventions for sepsis.
Main Methods:
- Systematic review and critical appraisal of preclinical and clinical evidence.
- Analysis of VISTA expression profiles across sepsis stages.
- Evaluation of studies on VISTA-targeted therapies.
Main Results:
- VISTA exhibits stage-specific biphasic effects in sepsis.
- Early phase: VISTA may reduce hyperinflammation and preserve organ barriers.
- Late phase: Aberrant VISTA upregulation may drive immunosuppression and T cell hyporesponsiveness.
Conclusions:
- VISTA is a central regulator of the sepsis immunoregulatory network.
- Targeting VISTA presents a novel therapeutic avenue for sepsis.
- Precision immunomodulatory strategies targeting VISTA show therapeutic promise.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
